SEC Form D · filed February 8, 2022
Emeryville Bioscience Center REIT, LLC
Industry
REITS and Finance
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Thomas Shin · BOSTON, MADirectorAdam Sichol · BOSTON, MADirectorJamison Peschel · BOSTON, MADirectorJoseph Van Saun · BOSTON, MADirectorYannick Garneau · BOSTON, MADirectorBrian O'Connor · CHICAGO, ILDirectorR. L. Phegley, Jr · Dallas, TXDirectorGeoff Dover · Wilmington, DEDirectorMichael Bissonnette · Longmont, CODirectorEdwin Dearborn · Las Vegas, NVDirectorNancy J. Domaille · St. Cloud, MNDirectorChris R. Coborn · St. Cloud, MNDirectorJoseph G. Torborg · St. Cloud, MNDirectorGregory V. Windfeldt · St. Cloud, MNDirectorDavid N. Miller · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗